c-Met is a new prognostic biomarker in glioblastoma patients

被引：0
|
作者：
Petterson, Stine A. [1 ,2 ]
Hermansen, Simon K. [1 ,2 ]
Dahlrot, Rikke H. [1 ,2 ,3 ]
Hansen, Steinbjorn [2 ,3 ]
Kristensen, Bjarne W. [1 ,2 ]
机构：
[1] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark
[2] Univ Southern Denmark, Inst Clin Res, Odense, Denmark
[3] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark
来源：
APMIS | 2014年 / 122卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [31] c-MET as a target for MET inhibitors in patients with poor prognostic pancreatic adenocarcinoma following completed surgical resection
    Neuzillet, Cindy
    Cros, Jerome
    Tijeras-Raballand, Annemilai
    Moroch, Julien
    de Mestier, Louis
    Baia, Maryse
    Bedossa, Pierre
    Paradis, Valerie
    Sauvanet, Alain
    Bachet, Jean-Baptiste
    Raymond, Eric
    Hammel, Pascal
    Couvelard, Anne
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [32] Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy
    Li, Yunqing
    Guessous, Fadila
    DiPierro, Charles
    Zhang, Ying
    Mudrick, Tucker
    Fuller, Lauren
    Johnson, Elizabeth
    Marcinkiewicz, Lukasz
    Engelhardt, Matthew
    Kefas, Benjamin
    Schiff, David
    Kim, Jin
    Abounader, Roger
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (02) : 376 - 385
  • [33] An essential role of c-Met/HGF signaling in glioblastoma initiating cells
    Joo, Kyeung Min
    Lee, Jeongwu
    Kang, Yun Jung
    Jin, Juyoun
    Kang, Bong Gu
    Kim, Mi Hyun
    Lee, Se Jeong
    Jo, Mi-Young
    Kim, Hyunggee
    Nam, Do-Hyun
    CANCER RESEARCH, 2009, 69
  • [34] Regulation of reprogramming factors by c-Met signaling in glioblastoma stem cells
    Li, Yunqing
    Li, Angela
    Ying, Mingyao
    John, Laterra
    CANCER RESEARCH, 2011, 71
  • [35] C-MET: A POTENTIAL CANDIDATE OF GLIOBLASTOMA CANCER STEM CELL MARKER
    Nam, Do-Hyun
    Joo, Kyeung Min
    Jin, Juyoun
    Kim, Mi Hyun
    Kong, Doo-Sik
    Lee, Jung-Il
    Park, Kwan
    Kim, Jong Hyun
    NEURO-ONCOLOGY, 2008, 10 (05) : 903 - 903
  • [36] The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab
    Carvalho, Bruno
    Lopes, Jose Manuel
    Silva, Roberto
    Peixoto, Joana
    Leitao, Dina
    Soares, Paula
    Fernandes, Ana Catarina
    Linhares, Paulo
    Vaz, Rui
    Lima, Jorge
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [37] CROSSTALK OF THE HGF/C-MET AND TGF-B PATHWAYS IN GLIOBLASTOMA
    Papa, E.
    Weller, M.
    Szabo, E.
    NEURO-ONCOLOGY, 2017, 19 : 64 - 64
  • [38] c-Met as a new marker of cellular senescence
    Boichuck, Maria
    Zorea, Jonathan
    Elkabets, Moshe
    Wolfson, Marina
    Fraifeld, Vadim E.
    AGING-US, 2019, 11 (09): : 2889 - 2897
  • [39] The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab
    Bruno Carvalho
    José Manuel Lopes
    Roberto Silva
    Joana Peixoto
    Dina Leitão
    Paula Soares
    Ana Catarina Fernandes
    Paulo Linhares
    Rui Vaz
    Jorge Lima
    Scientific Reports, 11
  • [40] C-MET as a Biomarker in Patients with Surgically Resected Non-Small Cell Lung Cancer
    Tsakonas, G.
    Hirsch, F. R.
    Ekman, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2124 - S2125
12345